Morning Wrap

Today ’s Newsflow Equity Research 17 Sep 2015 Upcoming Events Select headline to navigate to article

FBD Holdings Issue of €70m convertible bond to Fairfax Company Events Financial 23-Sep ; Q4 2015 Results

CRH Positive outlook from Apogee will be complemented by recent acquisition

Paper & Packaging US liner board export production declines in August

Tullow Oil Ugandan commentary on crude development adds uncertainty

US Economic View Federal Reserve to decide on first Economic Events interest rate rise today Ireland

United Kingdom 17-Sep Retail Sales Ex Auto Fuel YoY

United States 17-Sep Philadelphia Fed Business Outlook FOMC Rate Decision Housing Starts Initial Jobless Claims

Europe

Goodbody Capital Markets Equity Research +353 1 6419221 Equity Sales +353 1 6670222 Bloomberg GDSE

Goodbody Stockbrokers (trading as Goodbody) is regulated by the Central . For the attention of US clients of Goodbody Securities Inc, this third-party research report has been produced by our affiliate Goodbody Stockbrokers. Please see the end of this report for analyst certifications and other important disclosures. Goodbody Morning Wrap

FBD Holdings Issue of €70m convertible bond to Fairfax Financial

Recommendation: Restricted FBD yesterday announced a €70m convertible bond private placement with Fairfax Financial, Closing Price: €6.75 subject to shareholder approval. Ahead of the approval, FBD yesterday issued a Tier 2 bond to Fairfax with a 12% coupon, bolstering capital immediately, which will be exchanged for Eamonn Hughes the convertible bond within 7 days of the required shareholder approval. Please note that +353-1-641 9442 Goodbody is a corporate advisor to FBD. The convertible bond is Solvency II compliant and [email protected] carries a 7% coupon, payable semi-annually. The conversion share price is set at €8.50, a 37% premium to the price ahead of the announcement. Unless previously redeemed, the bond will be exercisable from year 3 to year 10 in the event that the 30-day volume weighted share price exceeds the conversion price for 180 days, automatically converting into ordinary shares in FBD at the conversion price. Should the bond convert, we estimate Fairfax would end up with a c.19% stake in FBD.

The 7% coupon is much cheaper than where recent speculation had pitched where a possible straight debt deal may have been for FBD. We anticipate this lower coupon could add c.11% to net income in 2018 relative to the straight debt deal, but post conversion as much as c.23%. However, the higher share count post conversion would leave FY19 operating EPS unchanged. From a value perspective, the higher equity content post conversion pares c.50bps+ from normalised ROE, though would be offset by the higher NAV per share (if converted at premium to NAV), implying a modest boost to value. Significant reserve strengthening in the H1 results drove some uncertainty over capital levels, raising FBD’s potential Cost of Equity. The convertible bond is a vote of confidence in both FBD management and possibly Fairfax’s view on the adequacy of the reserve strengthening. Home…

CRH Positive outlook from Apogee will be complemented by recent acquisition

Apogee (a peer of CRH’s US Building Envelope division, represents 3-4% of group EBITDA in Recommendation: Buy FY14) has reported Q2 (to end of August) earnings of $0.50. This was broadly in line with Closing Price: €26.19 consensus ($0.51) and up over 40% yoy, reflecting a strong margin performance (+370bps) Robert Eason on sales growth of 4% (14% Q1). The latter was driven by strong mid-teens growth in the +353-1-641 9271 US products business, offset by project timing in the installation business and adverse [email protected] currency movements.

While management has moderated its top-line expectations for the FY to high-single digit from 10-15% (reflects impact of construction delays), it has left earnings guidance unchanged at $2.10-2.25 (consensus $2.30). Its backlog is up 7% yoy and given its high level, management notes “visibility one year out is stronger than it has ever been”.

CRH’s US Building Envelope business reported lfl sales growth of 6% in H1, with management also highlighting the impact of some delays in project timing. Apogee’s comments on the pipeline are therefore encouraging. In addition, CRH’s business will benefit from the recent acquisition of C.R. Laurence which is a complementary business given that it is a specialist supplier of high-value custom hardware to the glass / glazing industry. This business has sales of $570m and EBITDA of $115m, with a conservative synergy assumption of $40m.

Home…

Page 2 17 Sep. 15 Goodbody Morning Wrap

Paper & Packaging US liner board export production declines in August

The latest data from the US shows that corrugated box shipments increased by 0.5% in David O’Brien +353-1-641 9230 August to 30.9bn m2, slowing from 1-2% growth in the preceding six months. This leaves the david.a.o’[email protected] ytd figure at +1.4%. Containerboard inventories increased by 66k tonnes compared to the average monthly increase for August of 1k. Interestingly, from a European perspective, Robert Eason +353-1-641 9271 production of liner board for export declined by 4% yoy in August representing the second [email protected] consecutive month of decline.

It is encouraging to see export production decline again in August given that the European market is a major destination of US kraftliner exports. This is supportive of the current efforts to increase both kraftliner and testliner grades in Europe.

Home…

Tullow Oil Ugandan commentary on crude development adds uncertainty

Having made the initial discovery on the shores of Lake Albert almost a decade ago (Q1’06) Recommendation: Hold developments in Uganda have since been slow and frustrated. While commentary yesterday Closing Price: £2.09 from the Ugandan Energy minister was positive in that production permits (yet to be Gerry Hennigan awarded to Tullow and Total) are now expected to be issued by year-end and “could be +353-1-641 9274 sooner”, commentary elsewhere serves to only add uncertainty and confusion. Foremost in [email protected] that regard is an indication that the government is in the process of revising the PSA model and that despite apparent agreement on a pipeline through Kenya the route is “still under discussion”.

Discussion with Tullow suggests any changes to the PSA terms are likely to impact future agreements and not applied retrospectively. With discussions still ongoing on the pipeline route, and at least one of the partners (Total) apparently favouring a Tanzanian route as a more secure option, the Ugandan statement that construction of the pipeline will commence in c19 months may again prove unrealistic.

At the very least, the Ugandan government timeline for the commencement of crude distribution by 2019 (we assume 2020) is in danger of being pushed out even further.

Home…

Page 3 17 Sep. 15 Goodbody Morning Wrap

US Economic View Federal Reserve to decide on first interest rate rise today

All eyes will be on the Federal Reserve today with a decision on whether to raise rates for the Juliet Tennent +353-1-641 9469 first time in 9 years pending. While the US labour market has been steadily improving [email protected] (unemployment rate down to 5.1% from 6.1% a year ago) and economic growth accelerating (3.7% annualised yoy in Q2), China driven volatility in financial markets is likely to stay the hand of the Fed, at least for now. Since the beginning of August the probability of a rate hike following today’s meeting has reduced from 40% to 32%, as uncertainty about the health of the Chinese economy has risen. In addition, concerns about the impact on dollar reliant emerging markets have been raised by a number of institutions including the IMF and the OCED who are both advising that the US Federal Reserve should delay any rate increase until financial conditions are more stable.

The improvement in US growth implies that the economy is ready for rate lift-off. However, today the Fed is faced with a dilemma. Should it delay raising rates until global financial conditions are more stable, and risk falling behind the curve domestically, or should it raise rates now and risk disrupting global markets further? Either way the US is poised to start to raise rates soon. We expect that a delayed rate hike today will be accompanied by a hawkish statement and a clear signal of intent for October’s meeting.

Home…

Page 4 17 Sep. 15 Goodbody Morning Wrap

Market Data Top 10 Covered Companies

Company Price Mkt Cap Absolute Relative to European Sector P/E (LC) (LCM) 1 Day 1 Week 1 Mth Ytd 1 Day 1 Week 1 Mth Ytd 2015f 2016f AIB Group 0.08 41,880 2.6 1.3 -7.1 1.3 1.0 1.8 -0.8 -4.1 26.0 29.2 CRH 26.19 21,362 0.5 -2.3 -4.7 31.6 -1.0 -1.8 1.7 24.6 23.4 14.4 13.62 18,856 0.5 -0.3 6.9 38.9 -1.0 0.2 14.1 31.5 13.1 15.2 IAG 5.98 12,156 0.3 3.5 10.2 23.0 -1.2 4.0 17.7 16.4 11.6 8.2 Wolseley 42.48 11,047 0.8 0.5 1.0 15.2 0.1 0.9 5.4 16.3 17.6 16.1 65.12 11,448 1.8 -0.1 -6.0 14.1 0.2 0.4 0.3 8.0 21.7 19.9 Bank of Ireland 0.35 11,270 -0.6 -0.6 -4.1 11.2 -2.1 -0.0 2.3 5.2 10.9 11.4 easyJet 17.61 6,938 0.3 -1.1 3.0 5.4 -0.3 -0.8 7.5 6.3 12.6 11.9 Mondi 14.09 6,842 -4.7 -4.3 -10.3 34.2 -6.1 -3.8 -4.2 27.0 14.7 14.0 Travis Perkins 20.60 5,088 1.4 1.5 -2.8 10.9 0.7 1.8 1.5 11.9 16.3 13.9

Indices ISEQ performance

% Price 1 Day 1 Week 1 Mth Ytd 7,000 ISEQ 6,492.26 0.34 -0.58 -0.43 24.26 6,500 FTSE 100 6,229.21 1.49 0.00 -4.91 -5.13 6,000 DAX 30 10,227.21 0.38 -0.74 -6.90 4.30 CAC 40 4,645.84 1.67 -0.40 -6.27 8.73 5,500

FTSE Eurofirst 300 1,427.55 1.57 -0.56 -6.58 4.31 5,000 Nasdaq 4,889.24 0.59 2.79 -3.15 3.23 4,500 S&P 500 1,995.31 0.87 2.74 -4.60 -3.09 Dow Jones 16,739.95 0.84 2.99 -4.22 -6.08 4,000 Sep-14 Dec-14 Mar-15 Jun-15 Sep-15 Nikkei 225 18,171.60 0.81 -3.19 -11.44 4.13

Exchange Rates

Current Px 1 day Px 1 Week Px Dec14 Avg Ytd

Stg/€ 0.728 0.734 0.727 0.776 0.728 STOXX 600 performance US$/€ 1.130 1.128 1.117 1.210 1.114 CHF/€ 1.094 1.098 1.092 1.202 1.061 420

JPY/€ 136.150 135.531 135.088 145.079 134.799 400

Bonds 380

Yield 1 Day Yld 1 Wk Yld 1 Mth Yld 3 Mth 360

US 2 Yr 0.81 0.00 0.81 0.08 0.12 340 US 10 Yr 2.30 0.01 0.10 0.10 -0.01 320

UK 2 Yr 0.66 0.02 0.03 -0.06 -0.01 300 Sep-14 Dec-14 Mar-15 Jun-15 Sep-15 UK 10 Yr 1.83 0.03 0.08 -0.06 -0.17

BD 2 Yr -0.23 0.01 0.01 -0.23 -0.02

BD 10 Yr 0.78 0.04 0.09 0.78 -0.01

Irish 10 Yr 1.37 0.05 0.05 0.13 -0.35

Commodities FTSE 250 performance

% Current 1 day 5 day 1 Mth 1 Yr 18,500

Brent (ICE $/bbl) 49.75 6.69 3.34 1.47 -49.77 18,000

Gasoline (NYM $/Gal) 1.38 3.69 0.89 -18.07 -45.99 17,500 Heat Oil (NYM $/Gal) 1.54 2.76 -0.55 -1.06 -44.08 17,000 Nat.Gas 2.66 -2.49 -1.23 -5.03 -33.42 16,500 16,000 Gold $/oz 1,117.60 1.05 1.48 -0.06 -9.30 15,500 Silver $/ozt 14.51 1.11 -0.48 -6.69 -22.61 15,000

Copper U$/MT 5,350.00 1.13 -0.04 3.76 -22.41 14,500

Wheat $/BU 4.88 -1.31 0.67 -3.60 -1.61 14,000 Sep-14 Dec-14 Mar-15 Jun-15 Sep-15

Source : FactSet

Page 5 17 Sep. 15 Goodbody Morning Wrap

Issuer & Analyst Disclosures

Analyst Certification The named Research Analyst certifies that: (1) All of the views expressed in this research report accurately reflect my personal views about any and all of the subject securities and issuers. (2) No part of my remuneration was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by me in this report.

Regulatory Information Goodbody Stockbrokers, trading as Goodbody, is regulated by the Central Bank of Ireland. Goodbody is a member of the Irish Stock Exchange and the London Stock Exchange. Goodbody is a member of the FEXCO group of companies. This publication has been approved by Goodbody Stockbrokers. The information has been taken from sources we believe to be reliable, we do not guarantee their accuracy or completeness and any such information may be incomplete or condensed. All opinions and estimates constitute best judgement at the time of publication and are subject to change without notice. The information, tools and material presented in this document are provided to you for information purposes only and are not to be used or considered as an offer or the solicitation of an offer to sell or to buy or subscribe for securities.

Conflicts of Interest Goodbody Stockbrokers has procedures and policies in place to identify and manage any potential conflicts of interest that arise in connection with its research business. Goodbody Stockbrokers’ analysts and other staff who are involved in the preparation and dissemination of research operate and have a management reporting line that is independent to its Corporate Finance business. Information barriers are in place between the Corporate Finance arm and the Research arm to ensure that any confidential and or price sensitive information is handled in an appropriate manner.

Our Investment Research Conflicts of Interest Policy is available at Conflicts of Interest

Investors should be aware, that, where appropriate, research may be disclosed to the issuer(s) in advance of publication in order to correct factual inaccuracies only and not to materially amend the research in any way. Goodbody Stockbrokers is satisfied that it has operational procedures in place, which ensure that such disclosures will not compromise the report’s objectivity.

Goodbody was the co-lead manager in an offering of securities in Permanent TSB Group Holdings Plc in the last 12 months. Goodbody was the co-lead manager for Hibernia REIT Plc for a public fund raising in the past 12 months. Goodbody is acting as a financial advisor to CRH on the proposed acquisition of certain assets being disposed by Lafarge and Holcim. International Consolidated Airlines Group has been an investment banking client of Goodbody’s in the past 12 months. Goodbody Stockbrokers acts as corporate broker to AIB Group, , Datalex, FBD Holdings, First Derivatives, Grafton Group, Greencore, Hibernia REIT, ICG, Kingspan, Origin Enterprises, Paddy Power, UDG Healthcare, and UTV Media A complete list of the companies that Goodbody Stockbrokers makes a market in is available at Regulatory Disclosures

Page 6 17 Sep. 15 Goodbody Morning Wrap

Other disclosures

A description of this company is available at Company Descriptions

All prices used in this report are as at close of business of the previous working day unless otherwise indicated.

A summary of our standard valuation methods are available at Valuation Methodologies

A summary of share price recommendations and whether material investment banking services have been provided to these companies is available at Regulatory Disclosures

Other important disclosures are available at Regulatory Disclosures

Goodbody Stockbrokers updates its recommendations on a regular basis. A breakdown of all recommendations provided by Goodbody Stockbrokers is available at Regulatory Disclosures Where Goodbody Stockbrokers has provided investment banking services to an issuer, details of the proportion of buys, holds and sells attributed to that issuer will also be included. This is updated on a quarterly basis.

The date on which stock recommendations were first released for all stocks mentioned in this report are available at http://www.goodbody.ie/research_disclosures/regulatorydisclosures/index.html. If a different recommendation has been made in the previous twelve months, this will also be disclosed here.

Recommendation Definitions Goodbody Stockbrokers uses the terms “Buy”, “Sell” and “Hold. The term “Buy” means that the analyst expects the security to appreciate in excess of 10% over a twelve month period. The term “Sell” means that the security is expected to decline in excess of 10% over the next twelve months. The term “Hold” means that the analyst expects the security to neither appreciate more than 10%, or depreciate more than 10% over the next twelve months.

On 26th November, 2012, the terms “Add” and “Reduce” were removed from the Recommendation Definitions and both were replaced with the “Hold” recommendation. Any Previous Recommendation that refers to either an “Add” means that the analyst expected the security to appreciate by up to 15% over a twelve month period. Any Previous Recommendation to “Reduce” means that the analyst expected the security to decline by up to 15% over the next twelve months.

In the event that a stock is delisted the firm will automatically cease coverage. If however the firm ceases to cover a stock for any other reason the firm will disclose this fact.

Distribution of research to clients of Goodbody Securities Inc (GSI) in the US

GSI distributes third-party research produced by its affiliate, Goodbody Stockbrokers GSI is a member of FINRA and SIPC GSI does not act as a market-maker.

This information was current as of the last business day of the month preceding the date of the report. An affiliate of GSI may have acted, in the past 12 months, as lead manager/co-lead manager of a publicly disclosed offer of the securities in this company. Investors should be aware that an affiliate of GSI may have provided investment banking or non-investment-banking services to, and received compensation from this company in the past 12 months or may provide such services in the next three months. The term investment banking services includes acting as broker as well as the provision of corporate finance services, such as underwriting and managing or advising on a public offer. All transactions by US persons involving securities of companies discussed in this report are to be effected through GSI.

Disclaimer While all reasonable care has been taken in the production and dissemination of this report it is not to be relied upon in substitution for the exercise of independent judgement. Nothing in this report constitutes investment, legal, accounting or tax advice, or a representation that any investment or strategy is suitable or appropriate to your individual circumstances, or otherwise constitutes a personal recommendation to you.

Private customers having access, should not act upon it in anyway but should consult with their independent professional advisors. The price, value and income of certain investments may rise or may be subject to sudden and large falls in value. You may not recover the total amount originally invested. Past performance should not be taken as an indication or guarantee of future performance; neither should simulated performance. The value of securities may be subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of such securities.

All material presented in this report, unless specifically indicated otherwise is copyright to Goodbody Stockbrokers. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of Goodbody Stockbrokers.

Goodbody, Ballsbridge Park, Ballsbridge, 4, Ireland T (+353 1) 6670400 W www.goodbody.ie E [email protected] Page 7 17 Sep. 15